1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Malignant Fibrous Histiocytoma Global Clinical Trials Review, H1, 2014

Malignant Fibrous Histiocytoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Malignant Fibrous Histiocytoma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Fibrous Histiocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Fibrous Histiocytoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malignant Fibrous Histiocytoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Malignant Fibrous Histiocytoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Malignant Fibrous Histiocytoma 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Malignant Fibrous Histiocytoma to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Unaccomplished Trials of Malignant Fibrous Histiocytoma 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Sponsors 22
Top Companies Participating in Malignant Fibrous Histiocytoma Therapeutics Clinical Trials 23
Prominent Drugs 24
Latest Clinical Trials News on Malignant Fibrous Histiocytoma 25
May 12, 2009: Oncolytics Biotech Inc. Completes Patient Enrolment In U.S. Phase 2 Sarcoma Study For The Trial REO 014 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Sanofi 26
Clinical Trial Overview of Sanofi 26
Oncolytics Biotech Inc. 27
Clinical Trial Overview of Oncolytics Biotech Inc. 27
Daiichi Sankyo Company, Limited 28
Clinical Trial Overview of Daiichi Sankyo Company, Limited 28
Clinical Trial Overview of Top Institutes / Government 29
National Cancer Institute 29
Clinical Trial Overview of National Cancer Institute 29
Memorial Sloan Kettering Cancer Center 30
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 30
Children's Oncology Group 31
Clinical Trial Overview of Children's Oncology Group 31
Japan Medical Association 32
Clinical Trial Overview of Japan Medical Association 32
Societe Internationale d'Oncologie Pediatrique 33
Clinical Trial Overview of Societe Internationale d'Oncologie Pediatrique 33
Massachusetts General Hospital 34
Clinical Trial Overview of Massachusetts General Hospital 34
The University of Texas M. D. Anderson Cancer Center 35
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 35
University of Washington 36
Clinical Trial Overview of University of Washington 36
Five Key Clinical Profiles 37
Appendix 129
Abbreviations 129
Definitions 129
Research Methodology 130
Secondary Research 130
About GlobalData 131
Contact Us 131
Disclaimer 131
Source 132

List of Tables
Malignant Fibrous Histiocytoma Therapeutics, Global, Clinical Trials by Region, 2014* 6
Malignant Fibrous Histiocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Malignant Fibrous Histiocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Malignant Fibrous Histiocytoma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Malignant Fibrous Histiocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Malignant Fibrous Histiocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Malignant Fibrous Histiocytoma Therapeutics, Global, Clinical Trials by Phase, 2014* 15
Malignant Fibrous Histiocytoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 16
Malignant Fibrous Histiocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Malignant Fibrous Histiocytoma Therapeutics, Global, Suspended Clinical Trials, 2014* 19
Malignant Fibrous Histiocytoma Therapeutics, Global, Withdrawn Clinical Trials, 2014* 19
Malignant Fibrous Histiocytoma Therapeutics, Global, Terminated Clinical Trials, 2014* 19
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Malignant Fibrous Histiocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 21
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 26
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncolytics Biotech Inc., 2014* 27
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 28
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 29
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 30
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 31
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Medical Association, 2014* 32
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Societe Internationale d'Oncologie Pediatrique, 2014* 33
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 34
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 35
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 36

List of Figures
Malignant Fibrous Histiocytoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Malignant Fibrous Histiocytoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Malignant Fibrous Histiocytoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Malignant Fibrous Histiocytoma to Oncology Clinical Trials, G7 Countries (%), 2014* 12
Malignant Fibrous Histiocytoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Malignant Fibrous Histiocytoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Malignant Fibrous Histiocytoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 15
Malignant Fibrous Histiocytoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 16
Malignant Fibrous Histiocytoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 17
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 18
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 20
Malignant Fibrous Histiocytoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 21
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 22
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 23
Malignant Fibrous Histiocytoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
GlobalData Methodology 130

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.